Skip to main content
. 2018 Jul 2;9:1449. doi: 10.3389/fmicb.2018.01449

FIGURE 2.

FIGURE 2

Schematic representation of bacterial delivery vehicles that have been tested for use in allergy immunotherapy. (A) Live bacterial vehicles with various modes of delivery of allergens or allergen-derived peptides (red): intracellular expression (1), secretion (2), membrane- and cell wall display (3), pilus-mediated display (4); heterologous display (5). (B) Bacterial surface protein carriers; S-layer proteins (green) and albumin binding protein (yellow): recombinant expression of carrier proteins with allergen-derived peptides (1), isolation of surface proteins and chemical coupling to allergens or allergen-derived peptides (2).